Combined Effects of Talocrural MWM and Therapeutic US on Pain, Balance and Disability in Athletes With Ankle Sprain

March 4, 2025 updated by: Riphah International University

Combined Effects of Talocrural Mobilization With Movement and Therapeutic Ultrasound on Pain, Balance and Disability in Athletes With Ankle Sprain.

Combined Effects of Talocrural MWM and Therapeutic US on Pain, Balance and Disability in Athletes With Ankle Sprain. Study consist of two groups. One group receives conventional physiotherapy treatment conventional physiotherapy treatment including icing and ankle isometrics. Other receives Talocrural mobilization with therapeutic ultrasound therapy on ankle joint.

Study Overview

Detailed Description

Ankle sprain is a prevalent injury marked by harm to the ligaments that provide support to the ankle joint. Ligaments are resilient and pliable fibrous structures that establish a connection between bones, providing joint stability. Ankle sprains commonly arise from excessive rotation or bending of the foot, resulting in the stretching or tearing of ligaments. Talocrural mobilization is a therapy method that utilizes manual techniques to treat the Talocrural joint, which is the joint formed by the tibia, fibula, and talus bone in the ankle. This mobilization approach is designed to enhance joint function, expand range of motion, and alleviate symptoms related to limited movement or musculoskeletal disorders that impact the ankle joint.

Randomized Control Trial will be conducted at the Punjab Stadium over a 10-month period. The sample size, after considering a 10% attrition rate, will consist of 15 participants in each group. Group A, the control group, will receive conventional physiotherapy treatment including icing and ankle isometrics, while Group B will undergo Talocrural mobilization with therapeutic ultrasound therapy and conventional physiotherapy. Participants aged 18 to 40 years diagnosed with ankle sprain and experiencing ankle pain within the last six weeks will be included. Exclusion criteria involve a history of ankle or foot fractures, concurrent lower extremity injuries, neurological disorders affecting lower limb function, and recent ankle or foot surgeries within the last six months. Data collection tools include the Foot and Ankle Disability Index (FADI) for disability, Star Excursion Balance Test (SEBT) for balance, and Numeric Pain Rating Scale (NPRS) for pain intensity. The study will involve pre and post assessments over a 6-week duration, analyzing changes within and between groups using statistical tests such as paired sample t-test, Wilcoxon signed rank test, independent sample t-test, and Mann Whitney U test. The Talocrural mobilization protocol for Group B will comprise five sessions per week, each lasting 40 minutes, including 20 minutes of therapeutic ultrasound and 20 minutes of Talocrural mobilization. The data will be analyzed using SSP for Windows software version 25.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Lahore, Punjab, Pakistan, 54000
        • Punjab Stadium

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Athletes age 18 to 40 years
  • Patients diagnosed with ankle sprain.
  • Onset of ankle pain during last six weeks.

Exclusion Criteria:

  • Previous history of ankle or foot fractures.
  • Concurrent lower extremity injuries affecting pain, balance, and disability assessment
  • Any neurological disorders affecting lower limb function.
  • Recent ankle or foot surgeries within the last six months.
  • Planned surgeries in next 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
Experimental group receive Talocrural mobilization with therapeutic ultrasound therapy.
Mobilization with movement alongwith the therapeutic ultrasound
Other: Control Group
Control Group receive the conventional physiotherapy treatment including icing and ankle isometrics.
Ankle isometrics, calf stretches, icing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Athlete disability index
Time Frame: 6 weeks
The Athlete Disability Index (ADI) is a self-administered questionnaire specifically designed to assess the level of disability experienced by athletes due to low back pain (LBP)
6 weeks
Berg balance scale
Time Frame: 6 weeks
The Berg Balance Scale (BBS) is a popular clinical tool for assessing balance and fall risk in older persons. Katherine Berg created it to assess balance during various activities.
6 weeks
Numeric Pain Rating Scale (NPRS)
Time Frame: 6 weeks
The Numeric Pain Rating Scale (NPRS) is a widely used tool for assessing subjective experiences, particularly pain intensity.
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Adeela Arif, MS, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2024

Primary Completion (Actual)

August 1, 2024

Study Completion (Actual)

September 30, 2024

Study Registration Dates

First Submitted

March 4, 2025

First Submitted That Met QC Criteria

March 4, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 4, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • Aman Naveed

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ankle Sprains

Clinical Trials on talocrural MWM and Therapeutic US

Subscribe